Common Household Spice Could Mess With Your Medications
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources.
Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content.
A new study suggested that certain types of cinnamon products could interfere with some medications due to their metabolic impacts.
Researchers from the National Center for Natural Products Research (NCNPR) at the University of Mississippi illustrated this by testing the absorption of medications following cinnamon intake in a material simulating fasting gastric fluid.
"People who suffer from chronic diseases – like hypertension, diabetes, cancer, arthritis, asthma, obesity, HIV, AIDS or depression – should be cautious when using cinnamon or any other supplements," Shabana Khan, a principal scientist in the natural products center, said in the press release, adding "By definition, supplements are not meant to treat, cure or mitigate any disease."
Why It Matters
The common spice is found in many homes, restaurants, and coffee houses and while researchers say having a little of it is harmless, larger quantities could cause potential medication efficacy issues.
It has long been known to have good metabolic and anti-inflammatory properties and thus has been marketed as supplements in different forms, including oils, powder and capsules.
What To Know
The study from the NCNPR says not knowing the source and quantity of cinnamaldehyde in the cinnamon can create dangerous situations, especially for those with chronic conditions like diabetes, heart disease, cancer and depression.
When taken in large doses, like those which can be found in some supplements, it can lead to a change in how quickly the large intestine can absorb the medicine, and thus, how effective the treatment will be on an individual.
Researchers tested using cinnamaldehyde, the active component that gives the spice its scent and flavor.
They found that the absorption of medications into the simulated gastric fluid was slowed after adding cinnamaldehyde in comparison to the fluid that did not have it added.
While the results aren't definitive, they do point in a direction of danger, leading researchers to caution medication takers and seek further research.
NCNPR Associate Director Amar Chittiboyina said the issues don't extend to all cinnamon products.
He said cinnamon oil doesn't have the same risk of drug interactions as cinnamon bark, which can have a large amount of coumarin, a blood thinner. This is mostly found in Cassia cinnamon from southern China, according to Chittiboyina.
"In contrast, true cinnamon from Sri Lanka carries a lower risk due to its reduced coumarin content," he explained in the press release. "Coumarin's anticoagulant properties can be hazardous for individuals on blood thinners."
In this stock image, cinnamon is seen in Berlin on January 20.
In this stock image, cinnamon is seen in Berlin on January 20.What People Are Saying
Bill Gurley, a principal scientist in the Ole Miss center and co-author of the study, said: "We know there's a potential for cinnamaldehyde to activate these receptors that can pose a risk for drug interactions. That's what could happen, but we won't know exactly what will happen until we do a clinical study."
Shabana Khan, a principal scientist in the natural products center, said in the press release: "Health concerns could arise if excessive amounts of supplements are consumed without the knowledge of health care provider or prescriber of the medications. Overconsumption of supplements could lead to a rapid clearance of the prescription medicine from the body, and that could result in making the medicine less effective."
What Happens Next?
Gurley said a clinical study is needed to further study the effects of cinnamaldehyde on patients' medication consumption and efficacy of those medications.
While those studies are not yet completed, researchers say people should talk to their doctor before adding any cinnamon supplements to their diet in addition to medications.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Hamilton Spectator
24 minutes ago
- Hamilton Spectator
Doctors, health experts call on N.S. to cover birth control and HIV-prevention drug
HALIFAX - Nova Scotia physicians and other sexual health experts are calling on the provincial government to fund birth control and increase access to a medication used to prevent HIV. Four doctors, the head of the Halifax Sexual Health Centre, and a pharmacy professor made the comments today at a legislature committee hearing in Halifax. Abbey Ferguson with the Halifax Sexual Health Centre says PrEP — an antiviral medication that prevents HIV transmission — is so expensive that many people who would benefit from the drug are not able to take it. The drug is estimated to cost between $200 and $250 per month. Dr. Melissa Brooks, the medical co-director of the Reproductive Options and Services Clinic, says the province's pharmacare plan is so restrictive that it often doesn't help those who cannot afford their preferred birth control option. Kari Ellen Graham, with Access Now Nova Scotia, urged the provincial government to sign on to the federal government's pharmacare program, which helps fund birth control. So far only P.E.I., Manitoba, British Columbia, and the Yukon have signed up to the federal pharmacare program. This report by The Canadian Press was first published June 10, 2025. Error! Sorry, there was an error processing your request. There was a problem with the recaptcha. Please try again. You may unsubscribe at any time. By signing up, you agree to our terms of use and privacy policy . This site is protected by reCAPTCHA and the Google privacy policy and terms of service apply. Want more of the latest from us? Sign up for more at our newsletter page .
Newsweek
an hour ago
- Newsweek
Iron May Rain From Sand Clouds on Newly-Discovered Planet
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. Dusty clouds made of sand—that may rain iron—blanket a giant planet orbiting a young, sun-like star just 310 light-years from Earth, the James Webb Space Telescope has revealed. The discovery was made by an international team of astronomers led from the Space Telescope Science Institute (STScI) in Baltimore Maryland. Around the star—dubbed "YSES-1"—the researchers also directly observed another giant exoplanet around which is a potentially multiple-moon-forming circumplanetary disk. "This work highlights the incredible abilities of JWST to characterize exoplanet atmospheres," said paper author and astronomer Evert Nasedkin of Trinity College Dublin, Ireland, in a statement. "With only a handful of exoplanets that can be directly imaged, the YSES-1 system offers unique insights into the atmospheric physics and formation processes of these distant giants." An artist's impression of the planets of the star system YSES-1. An artist's impression of the planets of the star system YSES-1. Ellis Bogat Using Webb's Near InfraRed Spectrograph (NIRSpec), the team were able to capture the two planets—which are both several times larger than Jupiter, and orbit out far from their host star—in a single exposure. This has provided what lead author and STScI physicist Kielan Hoch calls "the most detailed dataset of a multi-planet system to date." Nasedkin added: "Directly imaged exoplanets—planets outside our own solar system—are the only exoplanets that we can truly take photos of. "These exoplanets are typically still young enough that they are still hot from their formation—and it is this warmth, seen in the thermal infrared, that we as astronomers observe." By recording the light coming from the two exoplanets, the team were able to unpick the signals that reveal the chemical makeup of the gas giant's atmospheres. "When we looked at the smaller, farther-out companion—known as YSES-1c—we found the tell-tale signature of silicate clouds in the mid-infrared," said Nasedkin. "Essentially made of sand-like particles, this is the strongest silicate absorption feature observed in an exoplanet yet." The team's analysis also indicated that the clouds contain iron, which may fall from the clouds down into the planet as rain. "We believe this is linked to the relative youth of the planets: younger planets are slightly larger in radius, and this extended atmosphere may allow the cloud to absorb more of the light emitted by the planet." The circumplanetary disk is the inner planet, YSES-1b, meanwhile, presents something of a mystery. Only three other such disks have been identified to date, but they are all around objects that are significantly younger than YSES-1b—leading to questions as to how the newly discovered disk could be so long-lived. And that is far from the only puzzle that will need to be solved. "The YSES-1 system planets are also too widely separated to be explained through current formation theories, so the additional discoveries of distinct silicate clouds around YSES-1c and small hot dusty material around YSES-1b leads to more mysteries and complexities for determining how planets form and evolve," Hoch concluded. Do you have a tip on a science story that Newsweek should be covering? Do you have a question about exoplanets? Let us know via science@ Reference Hoch, K. K. W., Rowland, M., Petrus, S., Nasedkin, E., Ingebretsen, C., Kammerer, J., Perrin, M., D'Orazi, V., Balmer, W. O., Barman, T., Bonnefoy, M., Chauvin, G., Chen, C., De Rosa, R. J., Girard, J., Gonzales, E., Kenworthy, M., Konopacky, Q. M., Macintosh, B., Moran, S. E., Morley, C. V., Palma-Bifani, P., Pueyo, L., Ren, B., Rickman, E., Ruffio, J.-B., Theissen, C. A., Ward-Duong, K., & Zhang, Y. (2025). Silicate clouds and a circumplanetary disk in the YSES-1 exoplanet system. Nature.
Newsweek
an hour ago
- Newsweek
China Makes Childbirth Change Amid Falling Birth Rate
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. China is moving to expand access to pain relief during childbirth as part of efforts to encourage mothers to have more children. Newsweek reached out to the Chinese Foreign Ministry via email for comment outside of office hours. Why It Matters China has one of the world's lowest fertility rates, with an estimated 1.2 children per woman as of 2024. This marked a slight rise over 2023, but remains far below the replacement rate of 2.1. The government has rolled out an array of pro-natal policies, from child subsidies to extending insurance coverage to in vitro fertilization, but with little effect, raising concerns that the shrinking pool of young workers, coupled with the rising share of retirees, will drag on growth in the world's second-largest economy. A nurse takes care of a newborn baby at a hospital on May 11, 2025 in Lianyungang, Jiangsu Province of China. International Nurses Day falls on May 12 every year. A nurse takes care of a newborn baby at a hospital on May 11, 2025 in Lianyungang, Jiangsu Province of China. International Nurses Day falls on May 12 every year. Wang Chun/VCG via Associated Press What To Know By the end of this year, all tertiary hospitals—those with more than 500 beds—across China will be able to administer epidural anesthesia to pregnant women throughout the childbirth process, according to the country's health authorities, as reported by the state media outlet China Daily. All secondary hospitals, or those with more than 100 beds, will be capable of providing this service by 2027. These institutions will be expected to strengthen related infrastructure and protocols, including dedicated procedure rooms that meet a high standard of sterilization. Efforts were also updated to include pain relief procedures throughout labor, encompassing early and post-labor assessments, as well as the diagnosis and treatment of possible complications. Hospitals must continuously track hospital-acquired infections and improve information sharing between anesthesia and obstetrics departments to monitor patients' conditions better, the notice said. Anesthesia is administered to just 30 percent of mothers during labor in China, compared to around 67 percent in the United States, the health officials said. This hesitance is due to a shortage of anesthesiologists in some areas, unregulated costs of the procedure, and lingering misconceptions about possible side effects, according to experts cited by China Daily. What People Are Saying Yun Zhou, assistant professor of sociology at the University of Michigan, told Reuters: "Much of China's population decline is rooted in entrenched structural reasons. "Without fundamental structural transformations—from enhancing the social safety net to eliminating gender discrimination – the trend of population decline cannot be reversed." What Happens Next New measures continue to be introduced at both the central and local government levels. For example, Hohhot, the capital of the Inner Mongolia Autonomous Region, announced in January a subsidy of 10,000 yuan ($1,393) to couples who have their first child. However, experts are skeptical that these and other government-driven efforts are enough to reverse a demographic decline. Commonly cited obstacles to parenthood in China include long working hours, the rising cost of urban living, and a lack of support for women in the workplace.
